Priority 14 from the Liver Glycogen Storage Disease (International) PSP
| UNCERTAINTY: How to prevent and/or treat neurological problems in patients with liver Glycogen Storage Disease? (JLA PSP Priority 14) | |
|---|---|
| Overall ranking | 14 |
| JLA question ID | 0090/14 |
| Explanatory note |
As a result of acute and chronic periods of hypoglycemia in liver GSD, neurological symptoms can occur. This question emphasizes that more research is necessary to avoid these neurological complications. |
| Evidence |
For details of the evidence checked, please see the spreadsheet held on the JLA website. |
| Health Research Classification System category | Metabolic and endocrine |
| Extra information provided by this PSP | |
|---|---|
| Original uncertainty examples | How do we follow neurologic sequele and developement? ~ How do we monitor neurologic sequele and developement? |
| Submitted by | Patient, carer and healthcare professionals |
| PSP information | |
|---|---|
| PSP unique ID | 0090 |
| PSP name | International Glycogen Storage Disease PSP |
| Total number of uncertainties identified by this PSP | 72 (To see a full list of all uncertainties identified, please see the detailed spreadsheet held on the JLA website) |
| Date of priority setting workshop | 24 May 2019 |